Background Despite the significant benefits of laparoscopic surgery, limitations still exist. One of these limitations is the loss of several degrees of freedom. Robotic surgery has allowed surgeons to regain the two lost degrees of freedom by introducing wristed laparoscopic instruments.
Methods At the first Pelvic Surgery Meeting held in Brescia in June 2007, the participants focused on the role of robotic surgery in pelvic operations surgery for malignancy including prostate, rectal, uterine, and cervical carcinoma. All members of the interdisciplinary panel were asked to define the role of robotic surgery in prostate, rectal, and uterine carcinoma. All key statements were reformulated until a consensus within the group was achieved (Murphy et al., Health Technol Assess 2(i-v): 1998) . For the systematic review, a comprehensive literature search was performed in Medline and the Cochrane Library from January 1997 to June 2007. The keywords used were Da Vinci Ò , telemonitoring, laparoscopy, neoplasms for urology, colorectal, gynecology, visceral surgery, and minimally invasive surgery. The pelvic surgery meeting was supported by Olympus Medical Systems Europa. Results As of December 31, 2007 , there were 795 unit shipments worldwide of the Da Vinci Ò : 595 in North America, 136 in Europe, and 64 in the rest of the world (http://investor.intuitivesurgical.com/phoenix.zhtml?c=122 359&p=irol-faq#22324). It was estimated that, during 2007, approximately 50,000 radical prostatectomies were performed with the Da Vinci Ò robot system in the USA, reflecting market penetration of 60% of radical prostatectomies in the USA. This utilization represents 50% growth as in 2006 only 42% of all radical prostatectomies performed in the USA employed robotics. Conclusion While robotic prostatectomy has become the most widely accepted method of prostatectomy, robotic hysterectomy and proctectomy remain far less widely accepted. The theoretical benefits of the increased degrees of freedom and three-dimensional visualization may be outweighed in these areas by the loss of haptic feedback, increased operative times, and increased cost.
Keywords Robotic Á Consensus Á Surgery Laparoscopic surgery has produced clinical benefits for countless patients during the last two decades. However simultaneously, its limitations have also become very apparent. One of the most evident problems is the disruption of the natural coupling between the surgeon's hands and eyes by the interposition of an independently moving video camera. Other obstacles to natural motion include the fulcrum effect, the loss of tactile feedback, and the loss of two of the six degrees of freedom of the surgeon's hands. Robotic surgery has allowed surgeons to regain the two lost degrees of freedom by introducing wristed laparoscopic instruments. The value of using six degrees of freedom becomes most evident in complex surgical procedures, particularly if performed within a confined space such as the pelvis. The aim of this consensus statement was to review the evidence available to support the hypothesis that robotic surgery can overcome some limitations of laparoscopic surgery for prostate cancer, rectal cancer, and uterine cancer.
Methods
At the first Pelvic Surgery Meeting held in Brescia, June 2007, the participants focused on the role of robotic surgery in pelvic surgery including prostate, rectal cancer, and uterine carcinoma. Based on a review of the literature, European and US experts were invited to participate in the development of the consensus statement. All members of the interdisciplinary panel were asked to define the role of robotic surgery in prostate, rectal, and uterine cancer.
All key statements were reformulated until a consensus within the group was achieved [1] . Next these statements were presented to the experts. Comments from the discussion were collected and partly included in the manuscript. The final version of the consensus was approved by all experts.
For the systematic review, a comprehensive literature search was performed in Medline and the Cochrane Library from January 1997 to June 2007. The keywords used were Da Vinci Ò , telemonitoring, laparoscopy, neoplasms for urology, colorectal, gynecology, visceral surgery, and minimally invasive surgery. There were no restrictions regarding language of publication. Database searches combined the keyword laparoscopy (or laparosc* as the title word) with a condition-specific keyword. The conference was supported by Olympus whose headquarters are based in Hamburg. It was estimated that, during 2007, approximately 50,000 radical prostatectomies were performed with the Da Vinci Ò robot system in the USA, reflecting a market penetration of 60% of radical prostatectomies in the USA; this utilization represents 50% growth since in 2006, when only 42% of all radical prostatectomies performed in the USA employed robotics. Open radical prostatectomy will undoubtedly continue to decrease in numbers as more robotic systems become available and urologists become more facile with its use [40, 46, 47] . Indications have been expanded to other renal conditions (pyeloplasty [48] , partial renal resection [49] ), bladder (cystectomy [50, 51] , diverticulectomy [52] ), and prostate (adenomectomy [53] ). However, less expensive technologies should be found to overcome the drawbacks of conventional laparoscopy (i.e., 3D vision, degrees of instrument freedom). It is likely that robotic urology will be more widely utilized in the near future [54] .
Results

Robotics in urology
Robotics in rectal cancer
According to a systematic review of 4,224 patients, laparoscopic low anterior resection (LAR) with total mesorectal excision (TME) for rectal cancer has several short-term advantages compared with open LAR with TME [55] . Laparoscopic LAR with TME has resulted in less blood loss with unclear effects on blood transfusion requirements, quicker return to normal diet, and less pain as measured by narcotic use. No significant differences were found in length of resection margins or number of recovered lymph nodes. Mortality and leakage rates associated with laparoscopic and open LAR with TME were comparable, both ranging between 1% and 2%. However, LAR with TME is associated with longer operative time and higher cost [45] . Overall 5-year survival rates from retrospective data for laparoscopic LAR with TME have ranged from 62% to 92% [55] . The Cochrane review included one randomized controlled trial of 403 patients, which reported local recurrence rates of 6.6% and 4.1% and disease-free survival of 75% and 78% at 5 years following laparoscopic or open high anterior resection, respectively [56] . A meta-analysis of 2,071 patients confirmed that laparoscopic LAR with TME resulted in specimens oncologically comparable to its open counterpart, but offered a lower rate of wound infection (0% vs. 14%) and earlier postoperative recovery [57] .
Laparoscopic TME for rectal cancer is a technically challenging procedure due to the use of nonwristed instruments while working in the confined space of the pelvis. Recently, a hybrid technique has been advocated where robotic surgery was used along with laparoscopy to perform LAR [58] . A case-controlled study included 12 patients either treated with laparoscopic LAR with TME or laparoscopic LAR with robotic TME by one surgeon in 1 year [58] . Laparoscopic LAR with robotic TME resulted in a median of 4.4 h operative time, 104 ml estimated blood loss (EBL), 14 lymph nodes harvested, 3.8 cm distal margin, and 4.5 days length of stay (LOS). Similarly, laparoscopic LAR with TME resulted in a median of 4.3 h operative time, 150 cc EBL, 17 lymph nodes harvested, 3.5 cm distal margin, and 3.6 days LOS [58] . Another study by the same authors was performed on 33 consecutive patients who underwent laparoscopic LAR with robotic TME from 2004 to 2007 [59] . Uninvolved circumferential margins were obtained in all cases and postoperative mortality and morbidity were 0% and 12.8%, respectively. The median operative time was 4.7 h, the conversion rate was 2.6%, and the anastomotic leakage rate was 12.1%. Average LOS was 4 days, and no local recurrences were noted at 4-month follow-up.
Laparoscopic LAR with robotic TME is feasible and safe [59] ; however, although the stereoscopic vision and wristed instruments are available with the robot, operative time is increased [60] and the additional cost of robotics is of concern as is the loss of haptic feedback.
Robotics in uterine cancer
Fifteen papers have been published since 2005 [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] , all of which were small case reports with fewer than 20 patients per series. Two studies identified [72, 75] clear technical and medical benefits of robotics compared with conventional laparoscopy despite the lack of cost effectiveness. However, one gynecologic perspective is that, even though robotic hysterectomy may not have immediately apparent major patient benefits, it may be a very useful tool to shorten the learning curve and more quickly confer the benefits of laparoscopy to patients [76] .
Discussion
The advent of robotic surgery represents the latest and perhaps the most sophisticated method to date of overcoming the obstacles of standard laparoscopy. Robotic surgery conquers the challenges of limiting the degrees of freedom by allowing the surgeon's wrist action to be reflected in the effecter tips of the instrument. While the learning curve is undoubtedly steep, the potential rewards seem self-evident. However the exceptionally high cost of acquisition and of maintenance of the platform may be prohibitive, especially outside of the USA. The robot was developed to allow off-pump cardiac bypass surgery but was rapidly adapted by urologists for its ability to facilitate working with adequate degrees of freedom in a small space to allow a safe and cost-effective prostatectomy including urethral anastomosis. Some of the benefits of the increased degrees of freedom may be shared by other forms of pelvic surgery, although they have not yet been proven. One of the major limitations relative to rectal cancer surgery is the need for splenic flexure mobilization and high ligation of the inferior mesenteric artery and vein. These maneuvers require repositioning of the robot and its arms, which add significant time and therefore expense. However, conditional developmental work continues in both the gynecologic and rectal arenas. The explosion of laparoscopy over the past 20 years has resulted in a seemingly unquenchable market thirst for the next minimally invasive revolution. A variety of technical advances including natural orifice transluminal endoscopic surgery (NOTES), single part access (SPA) surgery, and robotics are all vying for attention and for adoption. Regardless of which, if any, of these modalities will become widely accepted, each is being evaluated and each will help further standardize laparoscopic instrumentation and procedural refinement. Robotic pelvic surgery certainly overcomes the obstacles associated with the loss of the degrees of freedom while working in a closely confined space, if suturing is needed. The additional degrees of freedom are of paramount importance, which may be why robotic prostatectomy has been more widely accepted than has robotic hysterectomy or robotic proctectomy. Moreover, although uterine and prostate surgery is limited to the pelvis, rectal surgery also requires upper abdominal dissection for vascular control and splenic flexure mobilization. These steps necessitate either repositioning the entire platform, which is very time consuming and therefore costly or adapting an alternative approach such as standard laparoscopy. In addition, certain mechanical benefits such as the tremor filter may be more than offset by the loss of haptic sensation. Furthermore, the reliance upon a stapled anastomosis in colorectal and abdominal anastomosis and the absence of any anastomosis in hysterectomy may also limit the attraction of robotic pelvic surgery for rectal cancer surgery. Nonetheless widespread enthusiasm continues as courses are offered and data are presented in these areas. As Kennedy and Brolmann have suggested in their recent publication [76] , the robot platform may allow enhanced or more standardized training in pelvic surgery, which may in turn shorten the surgeon's learning curve and improve the patient's outcome.
Conclusions
While laparoscopic prostatectomy is becoming the most widely practised form of prostatectomy in the USA, laparoscopic hysterectomy and proctectomy have not yet been shown to have significant advantage over standard laparoscopic techniques. Surgeons will continue to push the frontiers of minimally invasive surgery and towards that end will continue to hone their respective skills and strive to enhance patient benefits. There benefits may be more quickly achieved with a reduced learning curve afforded by robotic simulation. Furthermore, the prohibitive cost of the robotic platform within many health care systems may significantly reduce the rate of potential global adoption even if benefits can be proven.
